Results 141 to 150 of about 700,500 (193)

Heterologous prime-boost immunization induces protection against dengue virus infection in cynomolgus macaques. [PDF]

J Virol, 2023
Keelapang P, Ketloy C, Puttikhunt C, Sriburi R, Prompetchara E, Sae-Lim M, Siridechadilok B, Duangchinda T, Noisakran S, Charoensri N, Suriyaphol P, Suparattanagool P, Utaipat U, Masrinoul P, Avirutnan P, Mongkolsapaya J, Screaton G, Auewarakul P, Malaivijitnond S, Yoksan S, Malasit P, Ruxrungtham K, Pulmanausahakul R, Sittisombut N.   +23 more
europepmc   +1 more source

Longitudinal study comparing IgG antibodies induced by heterologous prime-boost COVID-19 vaccine. [PDF]

J Med Virol, 2023
Lin-Wang HT, Damiani LP, Farias EDS, Bajgelman MC, Gun C.   +4 more
europepmc   +1 more source

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.

Developments in biologicals, 2002
A generic approach to inducing high level CD8+ T cell responses would be of value for prophylactic and therapeutic immunisation against several infectious diseases. However, it has been very difficult to achieve such immune responses using available vaccination strategies. Malaria is one of several diseases against which a new generation of better CD8+
Hill, A, Reece, W, Gothard, P, Moorthy, V, Roberts, M, Flanagan, K, Plebanski, M, Hannan, C, Hu, J, Anderson, R, Degano, P, Schneider, J, Prieur, E, Sheu, E, Gilbert, S   +14 more
openaire   +2 more sources

Synergistic DNA + Adenovirus Prime-Boost Immunization in Metastatic Colorectal Cancer

, 2016
Heterologous combinations of DNA prime and viral boost immunizations elicit immune responses against different types of tumors and infectious diseases.
Xiang, Bo
core   +1 more source

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer. [PDF]

Front Immunol, 2023
Niavarani SR, St-Cyr G, Daniel L, Lawson C, Giguère H, Alkayyal AA, Tai LH.   +6 more
europepmc   +1 more source

Heterologous prime-boost vaccination against H5 avian influenza: Safety and immunogenicity of a MF59-adjuvanted, cell-culture derived H5N6 vaccine. [PDF]

Hum Vaccin Immunother
Van Twuijver E, Versage E, Jacobs RL, Hohenboken M.   +3 more
europepmc   +1 more source

Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse. [PDF]

Cancer Immunol Immunother
Huang CH, Chen JY, Chang HY, Hong WZ, Jiang YW, Lee CY, Wu CH, Lin YS, Tsai YY, Kao WL, Chao KSC, Huang KC.   +11 more
europepmc   +1 more source

Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study. [PDF]

Int J Infect Dis, 2023
Kohmer N, Stein S, Schenk B, Grikscheit K, Metzler M, Rabenau HF, Widera M, Herrmann E, Wicker S, Ciesek S.   +9 more
europepmc   +1 more source

A pilot study on a heterologous prime-boost approach for inducing an immune response against double-layered human rotavirus particles. [PDF]

BMC Res Notes
Alesheikh S, Tazarghi A, Tabarraei A, Kianmehr Z, Akhondi S, Soleimanjahi H, Azimi SA, Razavi Nikoo H.   +7 more
europepmc   +1 more source

Heterologous Prime-Boost with ChAdOx1-VZV Establishes Dual-Layer Immunogenicity Conferring Protective Potential Against Herpes Zoster. [PDF]

Vaccines (Basel)
Zhao J, Shao J, Sui X, Wei M, Ma X, Xu Z, Zhu T.   +6 more
europepmc   +1 more source